Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 105 citing articles:

Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis
Hiroki Kitakata, Jin Endo, Hidehiko Ikura, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1414-1414
Open Access | Times Cited: 96
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 56
Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis
Lin Wu, Yuxin Du, Litao Wang, et al.
Redox Biology (2024) Vol. 72, pp. 103157-103157
Open Access | Times Cited: 17
Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis
Jingxuan Cui, Yujia Chen, Qiannan Yang, et al.
Advanced Science (2024)
Open Access | Times Cited: 16
Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
Bowen Yin, Jingyi Ren, Xuanyi Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Ferroptosis in heart failure
Xinquan Yang, Nicholas K. Kawasaki, Junxia Min, et al.
Journal of Molecular and Cellular Cardiology (2022) Vol. 173, pp. 141-153
Open Access | Times Cited: 64
Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway
Qianqian Jiang, Xu Chen, Xue Tian, et al.
Phytomedicine (2022) Vol. 106, pp. 154439-154439
Closed Access | Times Cited: 62
Ferroptosis and Its Role in Chronic Diseases
Wenli Hu, Kehong Liang, Hong Zhu, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2040-2040
Open Access | Times Cited: 61
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
Junqi Huang, Rundong Wu, Linyi Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 55
Elabela ameliorates doxorubicin-induced cardiotoxicity by promoting autophagic flux through TFEB pathway
Deshu Chen, Wenjie Yu, Chongbin Zhong, et al.
Pharmacological Research (2022) Vol. 178, pp. 106186-106186
Closed Access | Times Cited: 45
Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol
Wei Yu, Chunjuan Chen, Chenxi Xu, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 08, pp. 2103-2123
Closed Access | Times Cited: 40
Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3–NFS1 axis in doxorubicin-induced cardiotoxicity
Yifan Wang, Xiaoying Ying, Yuehong Wang, et al.
Cellular Signalling (2023) Vol. 107, pp. 110655-110655
Closed Access | Times Cited: 25
Aloe-emodin alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis
Ying He, Junmin Xi, Jianguo Fang, et al.
Free Radical Biology and Medicine (2023) Vol. 206, pp. 13-21
Closed Access | Times Cited: 24
Berberine hydrochloride alleviates imatinib mesylate – induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis
Chengzhu Song, Dongning Li, Jie Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 2, pp. 1087-1098
Closed Access | Times Cited: 21
Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity
Yinghua Zeng, Xu Liao, Yuting Guo, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 838-848
Closed Access | Times Cited: 10
Molecular Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity
Lin Wu, Yingmei Zhang, Guizhen Wang, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 6, pp. 811-826
Open Access | Times Cited: 9
Salidroside pretreatment alleviates ferroptosis induced by myocardial ischemia/reperfusion through mitochondrial superoxide-dependent AMPKα2 activation
Bin Yang, Ying Xu, Jingzhi Yu, et al.
Phytomedicine (2024) Vol. 128, pp. 155365-155365
Open Access | Times Cited: 9
Berberine inhibits excessive autophagy and protects myocardium against ischemia/reperfusion injury via the RhoE/AMPK pathway
Fajia Hu, Tie Hu, Yamei Qiao, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 5
Open Access | Times Cited: 9
EGCG-NPs inhibition HO-1-mediated reprogram iron metabolism against ferroptosis after subarachnoid hemorrhage
Liyong Huang, Xue Wang, Yanning Zheng, et al.
Redox Biology (2024) Vol. 70, pp. 103075-103075
Open Access | Times Cited: 8
Dihydroartemisinin alleviates doxorubicin‐induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy
Zhi-hui Lin, Huaqiang Xiang, Yongwei Yu, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Closed Access | Times Cited: 8
Endurance exercise preconditioning alleviates ferroptosis induced by doxorubicin-induced cardiotoxicity through mitochondrial superoxide-dependent AMPKα2 activation
Liang Wang, Qiao Yang, Jingzhi Yu, et al.
Redox Biology (2024) Vol. 70, pp. 103079-103079
Open Access | Times Cited: 7
Uncovering the Cardioprotective Potential of Diacerein in Doxorubicin Cardiotoxicity: Mitigating Ferritinophagy-Mediated Ferroptosis via Upregulating NRF2/SLC7A11/GPX4 Axis
Rehab M El-Gohary, Asmaa H. Okasha, Alaa H. Abd El-Azeem, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 493-493
Open Access | Times Cited: 7
Spexin inhibits excessive autophagy‐induced ferroptosis to alleviate doxorubicin‐induced cardiotoxicity by upregulating Beclin 1
Wen Ou, Haiqiong Liu, Changhai Chen, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 21, pp. 4195-4213
Closed Access | Times Cited: 7
Roles of Ferroptosis in Cardiovascular Diseases
Yuting Guo, Wei Zhang, Xinger Zhou, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 32
Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms
Xiaofeng Li
Environmental Research (2023) Vol. 234, pp. 116504-116504
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top